Back to Search
Start Over
Osimertinib in Stage III EGFR -Mutated NSCLC - Game, Set, Match.
- Source :
-
The New England journal of medicine [N Engl J Med] 2024 Aug 15; Vol. 391 (7), pp. 652-654. - Publication Year :
- 2024
- Subjects :
- Humans
Acrylamides therapeutic use
Aniline Compounds therapeutic use
Indoles
Mutation
Neoplasm Staging
Piperazines therapeutic use
Pyrimidines
Standard of Care
Maintenance Chemotherapy methods
Maintenance Chemotherapy standards
Antineoplastic Agents therapeutic use
Carcinoma, Non-Small-Cell Lung drug therapy
Carcinoma, Non-Small-Cell Lung genetics
Carcinoma, Non-Small-Cell Lung pathology
ErbB Receptors antagonists & inhibitors
ErbB Receptors genetics
Lung Neoplasms drug therapy
Lung Neoplasms genetics
Lung Neoplasms pathology
Tyrosine Kinase Inhibitors therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1533-4406
- Volume :
- 391
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- The New England journal of medicine
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39141858
- Full Text :
- https://doi.org/10.1056/NEJMe2406495